Long-term improvement in renal function with sirolimus after early cyclosporine withdrawal in renal transplant recipients: 2-year results of the rapamune maintenance regimen study1 2-Reference-Cited by-同舟云学术

Long-term improvement in renal function with sirolimus after early cyclosporine withdrawal in renal transplant recipients: 2-year results of the rapamune maintenance regimen study1 2

Published:2003-07-27 Issue:2 Volume:76 Page:364-370
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Oberbauer Rainer,Kreis Henri,Johnson Robert W.G.,Mota Alfredo,Claesson Kerstin,Ruiz Juan Carlos,Wilczek Henryk,Jamieson Neville,Henriques Antonio C.,Paczek Leszek,Chapman Jeremy,Burke James T.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference15 articles.

1. Improved graft survival after renal transplantation in the United States, 1988 to 1996;Hariharan;N Engl J Med,1999

2. Post-transplant renal function in the first year predicts long-term kidney transplant survival;Hariharan;Kidney Int,2002

3. Association of chronic kidney graft failure with recipient blood pressure;Opelz;Kidney Int,1998

4. Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study. The Rapamune US Study Group;Kahan;Lancet,2000

5. A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts;MacDonald;Transplantation,2001

Cited by 168 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review of landmark studies on maintenance immunosuppressive regimens in kidney transplantation;Asian Biomedicine;2024-06-01

2. Cardiovascular effects of immunosuppression agents;Frontiers in Cardiovascular Medicine;2022-09-21

3. Comparison of Kidney Transplant Function, Lipid Metabolism Disorders, and Glucose and Hemoglobin Concentration in Transplant Patients Treated With Proliferation Signal Inhibitor (Everolimus) or Calcineurin Inhibitor (Tacrolimus);Transplantation Proceedings;2020-10

4. Early Switch to Mammalian Target of Rapamycin Inhibitors Is a Sustainable Treatment Approach in Renal Transplant Recipients: 7-Year Results;Transplantation Proceedings;2019-05

5. Everolimus in kidney transplant recipients at high cardiovascular risk: a narrative review;Journal of Nephrology;2019-04-27